|
May. 29, 2014 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080222503 |
Clinical trial of KIB-PCI in healthy Japanese children |
|
| version: date: |
DAIICHI SANKYO Co.,Ltd. |
||
http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html |
||
| 150 | ||
Interventional |
||
A multicenter, uncontrolled, open-label study |
||
2-3 |
||
Healthy Japanese children |
||
1) Subjects with history of H5N1 influenza |
||
| No limit | ||
| 19age old under | ||
Both |
||
Prophylaxis of new type of influenza infection |
||
investigational material(s) |
||
SRH antibody titer |
||
Neutralizing antibody titer |
||
| DAIICHISANKYO Co.,Ltd. | |
| KITASATO DAIICHI SANKYO VACCINE COMPANY, LIMITED |
| JapicCTI-142554 | |